| May 12, 2026 | management_change | Oracle elected Tomislav Mihaljevic to its Board of Directors, increasing the board size to 13 members. |
|---|
| Apr 6, 2026 | management_change | Oracle appointed Hilary Maxson as Chief Financial Officer with a $950,000 base salary and $26 million equity grant. |
|---|
| Mar 10, 2026 | earnings | Oracle announced financial results for its fiscal third quarter ended February 28, 2026. |
|---|
| Mar 10, 2026 | Guidance: capital_expenditures | 50.00 to not reported |
|---|
| Mar 10, 2026 | Guidance: non_gaap_eps_constant_currency | 1.92 to 1.96 |
|---|
| Mar 10, 2026 | Guidance: non_gaap_eps_growth_constant_currency | 15.00 to 17.00 |
|---|
| Mar 11, 2026 | mda_quarterly | Oracle maintained $6.3 billion available for its common stock repurchase program as of February 28, 2026, though no repurchases occurred during the three months ending on that date. The company's future repurchase activity will be influenced by factors such as working capital needs, capital expenditures, acquisitions, dividend payments, debt obligations, stock price, and broader economic and market conditions. Separately, several Section 16 officers and directors adopted Rule 10b5-1 trading plans. CEO Michael Sicilia initiated a plan on December 24, 2025, to sell up to 40% of approximately 161,886 restricted stock units, net of taxes, by October 9, 2026. Executive Vice Chair Jeffrey O. Henley adopted a plan on January 2, 2026, to exercise and sell up to 400,000 stock options expiring June 30, 2026. Chief Legal Officer Stuart Levey’s plan, adopted January 13, 2026, allows for the sale of up to 15,000 vested shares by October 15, 2026. These precleared plans facilitate scheduled stock transactions by key executives. |
|---|
| Dec 11, 2025 | mda_quarterly | Oracle maintains an active common stock repurchase program with approximately $6.3 billion remaining authorized as of November 30, 2025. No shares were repurchased during the three months ending November 30, 2025. The program lacks an expiration date, and the timing and volume of future repurchases will be influenced by factors such as working capital needs, capital expenditure requirements, acquisition strategies, dividend payments, debt repayment obligations, stock price performance, and broader economic and market conditions. Repurchases may occur through open market transactions or Rule 10b5-1 trading plans, and the program retains flexibility for acceleration, suspension, delay, or discontinuation.
Separately, Douglas Kehring, Oracle's Executive Vice President and Principal Financial Officer, established a new Rule 10b5-1 trading plan on October 9, 2025. This plan permits him to sell up to 50,648 Oracle shares, subject to specified limit prices, with a scheduled termination date of July 17, 2026. This arrangement adheres to Oracle’s Insider Trading Policy, and any actual sales will be publicly reported in subsequent Section 16 filings. |
|---|
